HCA Healthcare (NYSE:HCA) EVP Sells $1,843,990.68 in Stock

HCA Healthcare, Inc. (NYSE:HCAGet Free Report) EVP Michael Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

HCA Healthcare Stock Performance

NYSE HCA opened at $476.33 on Friday. The company has a market capitalization of $108.70 billion, a PE ratio of 18.41, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $478.88. The company has a 50-day simple moving average of $427.73 and a 200 day simple moving average of $391.34.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same period in the previous year, the company posted $4.90 earnings per share. The business’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HCA. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $26,000. Saudi Central Bank purchased a new position in HCA Healthcare during the 1st quarter valued at $26,000. WPG Advisers LLC purchased a new stake in shares of HCA Healthcare in the 1st quarter worth about $27,000. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare during the second quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in HCA Healthcare during the 2nd quarter valued at approximately $27,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of research reports. Barclays boosted their price target on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research note on Monday, October 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Wells Fargo & Company upped their price objective on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. TD Cowen boosted their target price on HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Finally, Truist Financial increased their price target on shares of HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research report on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $473.53.

Read Our Latest Stock Report on HCA

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.